Repros Therapeutics is Drug Discovery in United States that focus on reproductive system business. Founded in 1987. They cover business area such as developer, therapeutic drug, formulation, hormonal and reproductive system disorder, enclomiphene, an orally active proprietary small molecule compound, low testosterone, proellex, symptom, uterine fibroid, endometriosis, pharmaceutical company, innovative drug.
1987
( 37 years old in 2024 )
Reproductive System
-
2408 Timberloch Place, B-7
The Woodlands, TX 77380
United States
Private
developertherapeutic drugformulationhormonal and reproductive system disorderenclomiphenean orally active proprietary small molecule compoundlow testosteroneproellexsymptomuterine fibroidendometriosispharmaceutical companyinnovative drug
* We use standard office opening hours in near Repros Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Repros Therapeutics is Drug Discovery business from United States that founded in 1987 (37 years old in 2024), Repros Therapeutics business is focusing on Reproductive System.
Repros Therapeutics headquarter office and corporate office address is located in 2408 Timberloch Place, B-7 The Woodlands, TX 77380 United States.
Repros Therapeutics was founded in United States.
In 2024, Repros Therapeutics is currently focus on reproductive system sector.
Above is snippet of Google Trends for "reproductive system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Repros Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
